POMALIDOMIDE
Generic: POMALIDOMIDE
Sandoz IncManufacturer
ORALRoute
POMALIDOMIDEActive Substance
2026-08-31Original Approval
POMALIDOMIDE is FDA application ANDA220741, sponsored by SANDOZ. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
PLASMA CELL MYELOMA
2,437 reports
2
NEUTROPENIA
1,582 reports
3
PNEUMONIA
1,160 reports
4
OFF LABEL USE
1,118 reports
5
DEATH
970 reports
6
THROMBOCYTOPENIA
861 reports
7
ANAEMIA
806 reports
8
DRUG INEFFECTIVE
654 reports
9
FATIGUE
600 reports
10
PYREXIA
545 reports